ArticleACS omega2026
Amphipathic β‑Sheet-Forming Octapeptide Self-Assembly Using the Martini Potential Family.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amphipathic peptides can self-assemble into β-sheet-rich fibrils and hydrogels. The potential applications of these nanomaterials in biomedicine, drug delivery, and tissue engineering have sparked significant research. Current computational screens for amphipathic peptides heavily rely on coarse-grained molecular dynamics (CGMD) simulations using the Martini force field to ascertain the self-assembly potential of novel peptide sequences. This approach, however, showed limited success in self-assembling amphipathic peptides into experimentally observed β-sheet-rich hydrogels. We have systematically investigated this phenomenon using FKFEFKFE, an amphipathic octapeptide with a solved high-resolution self-assembled three-dimensional (3D) structure, as our model system. We first performed all-atom molecular dynamics (AAMD) simulations, which support the essential role of neutral capping groups in reproducing the cryogenic electron microscopy (Cryo-EM) structure. Accordingly, CGMD simulations were conducted to compare the efficacy of the Martini versions 2.1, 2.2, 2.2P, and 3. Surprisingly, Martini 2.1 was the best at maintaining the self-assembled bilayer structure of the peptide observed in Cryo-EM. The self-assembly of 20 mM FKFEFKFE peptides from a random initial arrangement was then examined via 5 μs CGMD simulations, further confirming that Martini 2.1 can successfully simulate the formation of a β-sheet-rich bilayer with phenylalanine side chains embedded between the two layers. Moreover, modifications to the Martini 3 potential and the use of small water models, which were promising for shorter-peptide self-assembly, have limited success. We further showed that configurational entropy performs better at characterizing the assembly of ordered structures than the routinely used aggregation propensity score. Though the FKFEFKFE peptide was exclusively examined, the comprehensive benchmarking conducted here provides valuable insights into the factors influencing the CGMD of peptide self-assembly. Overall, the results support the development of robust, reproducible CGMD protocols and analysis tools for studying self-assembling peptides, enabling the discovery of novel supramolecular structures and biomaterials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.